Results 151 to 160 of about 10,947 (186)
Some of the next articles are maybe not open access.
Non–Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose
PET Clinics, 2018F18 Flurodeoxyglucose (FDG) is a nonspecific PET tracer representing tumor energy metabolism, with common false-positive and false-negative findings in clinical practice. Non-small cell lung cancer is highly heterogeneous histologically, biologically, and molecularly.
openaire +2 more sources
Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography
Annals of Nuclear Medicine, 2009Significant uptake of the thyroid is often identified as an incidental finding on whole-body F18-fluorodeoxyglucose positron emission tomography (FDG-PET) for non-thyroid disease. Sometimes, it is a dilemma for radiologists to interpret clinical significance of thyroid uptake and give adequate recommendation for further evaluation.
openaire +2 more sources
Psychiatry Research: Neuroimaging, 2008
At present, there is still no consensus on the choice of the reference area in positron emission tomography (PET) studies of Alzheimer's disease (AD). In this study, PET scans with fluorodeoxyglucose-F18 were carried out in the following groups of subjects: 47 patients with probable AD, 8 patients with mild cognitive impairment, and 15 age-similar ...
Yakushev, Igor +9 more
openaire +3 more sources
At present, there is still no consensus on the choice of the reference area in positron emission tomography (PET) studies of Alzheimer's disease (AD). In this study, PET scans with fluorodeoxyglucose-F18 were carried out in the following groups of subjects: 47 patients with probable AD, 8 patients with mild cognitive impairment, and 15 age-similar ...
Yakushev, Igor +9 more
openaire +3 more sources
[Fluorodeoxyglucose F18(FDG)-probe guided biopsy].
Nederlands tijdschrift voor geneeskunde, 2010Although positron emission tomography-computed tomography (PET-CT) has improved the diagnosis of malignant and inflammatory abnormalities, histopathological examination is often required to supplement imaging examination in order to make a definite diagnosis.
Koen J, Hartemink +4 more
openaire +1 more source
European Heart Journal, 1986
Regional myocardial utilization of glucose can be assessed non-invasively in man with the sugar analogue F18-2-fluoro-2-deoxyglucose (FDG) and positron emission tomography (PET). The preliminary observations made in patients with different clinical forms of ischaemic heart disease using FDG and PET are reported.
CAMICI , PAOLO +5 more
openaire +3 more sources
Regional myocardial utilization of glucose can be assessed non-invasively in man with the sugar analogue F18-2-fluoro-2-deoxyglucose (FDG) and positron emission tomography (PET). The preliminary observations made in patients with different clinical forms of ischaemic heart disease using FDG and PET are reported.
CAMICI , PAOLO +5 more
openaire +3 more sources
Interaction of Colony-Stimulating Factors and Fluorodeoxyglucose F18 Positron Emission Tomography
Annals of Pharmacotherapy, 2002OBJECTIVE: To evaluate reports of altered diagnostic images with fluorodeoxyglucose F18 (FDG) positron emission tomography (PET) after treatment with colony-stimulating factors (CSFs). DATA SOURCES: Literature was identified by a MEDLINE search (1966–December 2001). Key search terms included granulocyte colony-stimulating factor, granulocyte—macrophage
Dmitri, Mayer, Edward M, Bednarczyk
openaire +2 more sources
European Journal of Radiology, 2018
This systematic review and meta-analysis was performed to assess the staging/restaging performance of F18-fluorodeoxyglucose (FDG) positron emission tomography (PET)/magnetic resonance imaging (MRI) in breast cancer.A comprehensive search was performed in PubMed databases for studies reporting the staging performance of F18-FDG PET/MRI in breast cancer
Chun-Yi, Lin +2 more
openaire +2 more sources
This systematic review and meta-analysis was performed to assess the staging/restaging performance of F18-fluorodeoxyglucose (FDG) positron emission tomography (PET)/magnetic resonance imaging (MRI) in breast cancer.A comprehensive search was performed in PubMed databases for studies reporting the staging performance of F18-FDG PET/MRI in breast cancer
Chun-Yi, Lin +2 more
openaire +2 more sources
International Journal of Cardiology, 1996
Planar reset myocardial thallium-201 chloride (201Tl)/F18-fluorodeoxyglucose (FDG) imaging has been shown to distinguish between viable and non-viable tissue. Twenty-five patients (60 +/- 9 years) with acute myocardial infarction were studied using this technique within 6 +/- 2 days (T1) after infarction and again after 42 +/- 4 days (T6).
Huitink, Johannes M. +4 more
openaire +4 more sources
Planar reset myocardial thallium-201 chloride (201Tl)/F18-fluorodeoxyglucose (FDG) imaging has been shown to distinguish between viable and non-viable tissue. Twenty-five patients (60 +/- 9 years) with acute myocardial infarction were studied using this technique within 6 +/- 2 days (T1) after infarction and again after 42 +/- 4 days (T6).
Huitink, Johannes M. +4 more
openaire +4 more sources
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2011
To assess the uptake of Fluorodeoxyglucose F18 ((18)F-FDG) coincidence single photon emission computed tomography (SPECT) imaging in lung tuberculoma.We enrolled 27 cases with 29 tuberculomas confirmed by clinical diagnosis. (18)F-FDG triple-head coincidence imaging was performed. The intensity of uptake was graded by visual method and the relationship
Ping-Xin, Lü +5 more
openaire +1 more source
To assess the uptake of Fluorodeoxyglucose F18 ((18)F-FDG) coincidence single photon emission computed tomography (SPECT) imaging in lung tuberculoma.We enrolled 27 cases with 29 tuberculomas confirmed by clinical diagnosis. (18)F-FDG triple-head coincidence imaging was performed. The intensity of uptake was graded by visual method and the relationship
Ping-Xin, Lü +5 more
openaire +1 more source
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly

